Skip to main content
SNDX logo

SNDX · Syndax Pharmaceuticals Inc · Analyst Estimates

Track SNDX — free
$18.80 +0.57 (+3.10%) At close · Sep 30
Market Cap
$1.63B
Shares
89.30M
Volume · Sep 30 1.73M Avg daily vol (3M) 1.61M

Analyst Estimates

Compare analyst forecasts for Syndax Pharmaceuticals Inc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 10:56 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.25136
-1.93483
-1.649
—
-1.68323
-1.69724
-1.95093
-1.68557
— — — —
EPS
analysts
Publication date not stated
— — —
10
— — — —
7
7
2
2
Revenue
USD
Publication date not stated
303600000
316099150
334898390
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.96165
-0.81594
0.1
—
-0.50936
-0.52311
-0.6543
-0.47061
— — — —
EPS
analysts
Publication date not stated
— — —
10
— — — —
8
7
2
2
Revenue
USD
Publication date not stated
389454730
463078540
614746430
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.58
-0.47025
-0.314
—
-0.38848
-0.39566
-0.45425
-0.38066
— — — —
EPS
analysts
Publication date not stated
— — —
10
— — — —
6
6
3
3
Revenue
USD
Publication date not stated
79000000
82799560
86000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.60127
-0.42595
-0.27
—
-0.35071
-0.35618
-0.40695
-0.34618
— — — —
EPS
analysts
Publication date not stated
— — —
10
— — — —
5
5
4
4
Revenue
USD
Publication date not stated
86900000
97024050
127885330
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —
Key facts CIK 1395937 CUSIP 87164F105 13F (30d) 7 filings 7 filers Visit website Investor relations